Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge

Julia Vipond; Richard Vipond; Emma Allen-Vercoe; Simon O. Clark; Graham J. Hatch; Karen E. Gooch; Joanna Bacon; Toby Hampshire; Helen Shuttleworth; Nigel P. Minton; Karen Blake; Ann Williams; Philip D. Marsh

doi:10.1016/j.vaccine.2006.05.025

Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge

Julia Vipond^*, Richard Vipond, Emma Allen-Vercoe, Simon O. Clark, Graham J. Hatch, Karen E. Gooch, Joanna Bacon, Toby Hampshire, Helen Shuttleworth, Nigel P. Minton, Karen Blake, Ann Williams, Philip D. Marsh

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Abstract

Putative TB vaccine candidates were selected from lists of genes induced in response to in vivo-like stimuli, such as low oxygen and carbon starvation or growth in macrophages, and tested as plasmid DNA vaccines for their ability to protect against Mycobacterium tuberculosis challenge in a guinea pig aerosol infection model. This vaccination method was chosen as it induces the Th1 cell-mediated immune response required against intracellular pathogens such as M. tuberculosis. Protection was assessed in the guinea pig model in terms of mycobacteria present in the lungs at 30 days post-challenge. Protection achieved by the novel candidates was compared to BCG (positive control) and saline (negative control). Four vaccines encoding for proteins such as PE and PPE proteins, a zinc metalloprotease and an acyltransferase, gave a level of protection that was statistically better than saline in the lungs. These findings have enabled us to focus on a sub-set of vaccine candidates for further evaluation using additional vaccination strategies.

Original language	English
Pages (from-to)	6340-6350
Number of pages	11
Journal	Vaccine
Volume	24
Issue number	37-39
DOIs	https://doi.org/10.1016/j.vaccine.2006.05.025
Publication status	Published - 11 Sept 2006

Bibliographical note

Funding Information:
This study was funded by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. We acknowledge the support of the staff in the Biological Investigations Group at HPA, Porton Down, the technical expertise of Kim Hatch, and members of the TB group for constructive discussions on vaccine candidate selection.

Keywords

DNA vaccine
Guinea pig
Mycobacterium tuberculosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2006.05.025

Cite this

Vipond, J., Vipond, R., Allen-Vercoe, E., Clark, S. O., Hatch, G. J., Gooch, K. E., Bacon, J., Hampshire, T., Shuttleworth, H., Minton, N. P., Blake, K., Williams, A., & Marsh, P. D. (2006). Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge. Vaccine, 24(37-39), 6340-6350. https://doi.org/10.1016/j.vaccine.2006.05.025

@article{3b0d63d0e15646ecbdf0ecc886461a99,

title = "Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge",

abstract = "Putative TB vaccine candidates were selected from lists of genes induced in response to in vivo-like stimuli, such as low oxygen and carbon starvation or growth in macrophages, and tested as plasmid DNA vaccines for their ability to protect against Mycobacterium tuberculosis challenge in a guinea pig aerosol infection model. This vaccination method was chosen as it induces the Th1 cell-mediated immune response required against intracellular pathogens such as M. tuberculosis. Protection was assessed in the guinea pig model in terms of mycobacteria present in the lungs at 30 days post-challenge. Protection achieved by the novel candidates was compared to BCG (positive control) and saline (negative control). Four vaccines encoding for proteins such as PE and PPE proteins, a zinc metalloprotease and an acyltransferase, gave a level of protection that was statistically better than saline in the lungs. These findings have enabled us to focus on a sub-set of vaccine candidates for further evaluation using additional vaccination strategies.",

keywords = "DNA vaccine, Guinea pig, Mycobacterium tuberculosis",

author = "Julia Vipond and Richard Vipond and Emma Allen-Vercoe and Clark, {Simon O.} and Hatch, {Graham J.} and Gooch, {Karen E.} and Joanna Bacon and Toby Hampshire and Helen Shuttleworth and Minton, {Nigel P.} and Karen Blake and Ann Williams and Marsh, {Philip D.}",

note = "Funding Information: This study was funded by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. We acknowledge the support of the staff in the Biological Investigations Group at HPA, Porton Down, the technical expertise of Kim Hatch, and members of the TB group for constructive discussions on vaccine candidate selection.",

year = "2006",

month = sep,

day = "11",

doi = "10.1016/j.vaccine.2006.05.025",

language = "English",

volume = "24",

pages = "6340--6350",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

number = "37-39",

}

TY - JOUR

T1 - Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge

AU - Vipond, Julia

AU - Vipond, Richard

AU - Allen-Vercoe, Emma

AU - Clark, Simon O.

AU - Hatch, Graham J.

AU - Gooch, Karen E.

AU - Bacon, Joanna

AU - Hampshire, Toby

AU - Shuttleworth, Helen

AU - Minton, Nigel P.

AU - Blake, Karen

AU - Williams, Ann

AU - Marsh, Philip D.

N1 - Funding Information: This study was funded by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. We acknowledge the support of the staff in the Biological Investigations Group at HPA, Porton Down, the technical expertise of Kim Hatch, and members of the TB group for constructive discussions on vaccine candidate selection.

PY - 2006/9/11

Y1 - 2006/9/11

N2 - Putative TB vaccine candidates were selected from lists of genes induced in response to in vivo-like stimuli, such as low oxygen and carbon starvation or growth in macrophages, and tested as plasmid DNA vaccines for their ability to protect against Mycobacterium tuberculosis challenge in a guinea pig aerosol infection model. This vaccination method was chosen as it induces the Th1 cell-mediated immune response required against intracellular pathogens such as M. tuberculosis. Protection was assessed in the guinea pig model in terms of mycobacteria present in the lungs at 30 days post-challenge. Protection achieved by the novel candidates was compared to BCG (positive control) and saline (negative control). Four vaccines encoding for proteins such as PE and PPE proteins, a zinc metalloprotease and an acyltransferase, gave a level of protection that was statistically better than saline in the lungs. These findings have enabled us to focus on a sub-set of vaccine candidates for further evaluation using additional vaccination strategies.

AB - Putative TB vaccine candidates were selected from lists of genes induced in response to in vivo-like stimuli, such as low oxygen and carbon starvation or growth in macrophages, and tested as plasmid DNA vaccines for their ability to protect against Mycobacterium tuberculosis challenge in a guinea pig aerosol infection model. This vaccination method was chosen as it induces the Th1 cell-mediated immune response required against intracellular pathogens such as M. tuberculosis. Protection was assessed in the guinea pig model in terms of mycobacteria present in the lungs at 30 days post-challenge. Protection achieved by the novel candidates was compared to BCG (positive control) and saline (negative control). Four vaccines encoding for proteins such as PE and PPE proteins, a zinc metalloprotease and an acyltransferase, gave a level of protection that was statistically better than saline in the lungs. These findings have enabled us to focus on a sub-set of vaccine candidates for further evaluation using additional vaccination strategies.

KW - DNA vaccine

KW - Guinea pig

KW - Mycobacterium tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=33747331970&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2006.05.025

DO - 10.1016/j.vaccine.2006.05.025

M3 - Article

C2 - 16781800

AN - SCOPUS:33747331970

SN - 0264-410X

VL - 24

SP - 6340

EP - 6350

JO - Vaccine

JF - Vaccine

IS - 37-39

ER -

Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this